We updated the design of this site on December 18, 2017. Learn more.
ClinicalTrials.gov Menu

Safety and Efficacy Study of Endothelial Progenitor Cell Capture Stent With 1 Months Dual Antiplatelet Therapy (INNOVATION)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT01394848
Recruitment Status : Terminated (Previous other study including EPC capture stent raised the issue of safety (significant high incidence of instent restenosis))
First Posted : July 14, 2011
Last Update Posted : December 4, 2013
Yuhan Corporation
Information provided by (Responsible Party):
Seung-Hwan Lee, Yonsei University

No Study Results Posted on ClinicalTrials.gov for this Study
  Recruitment Status : Terminated
  Primary Completion Date : January 2013
  Study Completion Date : January 2013